用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-02-08 AccNo: 0001144204-17-006649 Size: 1 MB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-01-30 AccNo: 0001144204-17-004432 Size: 1 MB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-01-13 AccNo: 0001144204-17-002171 Size: 1 MB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ PREM14A - Preliminary proxy statements relating to merger or acquisition Filed: 2016-12-05 AccNo: 0001144204-16-137923 Size: 2 MB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-11-30 AccNo: 0001144204-16-137294 Size: 881 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-09 AccNo: 0001564590-16-028688 Size: 7 MB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-11-03 AccNo: 0001144204-16-131242 Size: 148 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2016-11-03 09:00 Before Open:NAVIDEA BIOPHAR Earning Release 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-09-27 AccNo: 0001144204-16-125375 Size: 100 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-09-06 AccNo: 0001144204-16-122750 Size: 78 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接